Official funding announcement — preliminary draft
Funder: Stephanie Bogan Grantor
Opportunity number: RFA-FD-25-017
Official listed status: posted
Closing information: 2028-02-08 (official deadline clock time and time zone must be checked in NOFO)
Award disclosure: Official federal synopsis lists an award ceiling of 600,000; applicant-level applicability requires full-NOFO review.
Applicant categories in federal synopsis: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Federal synopsis
The purpose of this notice of funding opportunity (NOFO) is to support efficient and innovative natural history studies that advance medical product development in rare diseases/conditions with unmet needs. Through the support of natural history studies with high quality and interpretable data elements, FDA expects to address critical knowledge gaps, remove major barriers to progress in the field, exert a significant and broad impact on a specific rare disease or multiple rare diseases with similar pathophysiology, and facilitate rare disease product development.
Draft intake record. Eligibility, program terms, current amendments and applicant ceiling must be independently verified before publishing.